𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vitamin K3 and K5 are inhibitors of tumor pyruvate kinase M2

✍ Scribed by Jing Chen; Zheng Jiang; Beibei Wang; Yanguang Wang; Xun Hu

Book ID
116335807
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
972 KB
Volume
316
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Isotype-specific inhibitors of the glyco
Isotype-specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation
✍ Gilles A. Spoden; Sybille Mazurek; Dieter Morandell; Nicole Bacher; Michael J. A πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 505 KB

## Abstract Tumor cells express the glycolytic regulator pyruvate kinase subtype M2 (M2‐PK), which can occur in a tetrameric form with high affinity to its substrate phosphoenolpyruvate (PEP) and a dimeric form with a low PEP affinity. The transition between both conformations contributes to the co

Fecal dimeric M2-pyruvate kinase (tumor
Fecal dimeric M2-pyruvate kinase (tumor M2-PK) in the differential diagnosis of functional and organic bowel disorders
✍ Jinny Jeffery; Stephen J. Lewis; Ruth M. Ayling πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 109 KB

Background: Fecal inflammatory markers have been shown to be useful as noninvasive screening tools to differentiate patients with functional from organic bowel pathology. Of these markers calprotectin has been the most intensively studied. More recently, the dimeric isoform of M2-pyruvate kinase (tu